statistiche ricercatore

Continente	#
NA - Nord America	885
AS - Asia	765
EU - Europa	743
SA - Sud America	142
Continente sconosciuto - Info sul continente non disponibili	29
AF - Africa	22
OC - Oceania	2
Totale	2.588

Nazione	#
US - Stati Uniti d'America	851
IT - Italia	429
SG - Singapore	235
CN - Cina	179
VN - Vietnam	134
BR - Brasile	97
HK - Hong Kong	83
RU - Federazione Russa	76
DE - Germania	36
FR - Francia	34
GB - Regno Unito	31
BD - Bangladesh	30
ES - Italia	28
AR - Argentina	23
FI - Finlandia	21
IN - India	20
KR - Corea	20
IE - Irlanda	17
CA - Canada	16
ID - Indonesia	15
PL - Polonia	15
SE - Svezia	14
CH - Svizzera	10
NL - Olanda	10
JP - Giappone	7
TR - Turchia	7
EC - Ecuador	6
ET - Etiopia	6
IQ - Iraq	6
MX - Messico	6
PH - Filippine	6
AT - Austria	5
CO - Colombia	5
VE - Venezuela	5
ZA - Sudafrica	5
MA - Marocco	4
PK - Pakistan	4
SA - Arabia Saudita	4
UA - Ucraina	4
BE - Belgio	3
CR - Costa Rica	3
UZ - Uzbekistan	3
AU - Australia	2
BO - Bolivia	2
CL - Cile	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
EG - Egitto	2
GR - Grecia	2
GT - Guatemala	2
IR - Iran	2
MM - Myanmar	2
NO - Norvegia	2
AL - Albania	1
AZ - Azerbaigian	1
BB - Barbados	1
BM - Bermuda	1
CY - Cipro	1
DZ - Algeria	1
GA - Gabon	1
HN - Honduras	1
IL - Israele	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
KZ - Kazakistan	1
MT - Malta	1
MY - Malesia	1
NG - Nigeria	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PY - Paraguay	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	2.560

Nome	#
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis	419
Idiopathic erythrocytosis: a germline disease?	416
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy	341
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients	301
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)	263
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis	257
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis	249
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis	239
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution	103
Totale	2.588

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	36	0	0	0	0	0	0	0	0	13	7	7	9
2023/2024	216	7	9	13	13	18	25	27	11	31	20	20	22
2024/2025	619	24	52	40	24	39	29	31	18	58	102	75	127
2025/2026	1.345	167	90	121	157	123	57	232	57	85	122	43	91
2026/2027	372	74	107	147	44	0	0	0	0	0	0	0	0
Totale													2.588

Bicocca Open Archive